Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation

Tissue Barriers

Volumn 3, Issue 1, 2015, Pages

  Luettig, J ^a   Rosenthal, R ^a   Barmeyer, C ^a   Schulzke, J D ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Celiac disease; Claudin 2; Crohn s disease; HIV; IFN ; Inflammatory bowel disease; Tight junction; TNF ; Ulcerative colitis

Indexed keywords

ADALIMUMAB; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CLAUDIN 15; CLAUDIN 2; GAMMA INTERFERON; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MANNITOL; MITOGEN ACTIVATED PROTEIN KINASE; OCCLUDIN; OCCLUDIN 1; OCCLUDIN 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; RHO KINASE; STAT6 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR GATA 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; BACTERIAL TRANSLOCATION; CD8+ T LYMPHOCYTE; CELIAC DISEASE; CELL TRANSPORT; CROHN DISEASE; ELECTRON MICROSCOPY; ENTERITIS; ENTEROPATHY; EPITHELIAL MESENCHYMAL TRANSITION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC TRANSFECTION; GUT BARRIER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATORY BOWEL DISEASE; PERMEABILITY BARRIER; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TIGHT JUNCTION; ULCERATIVE COLITIS; UPREGULATION;

EID: 84958555991     PISSN: 21688362     EISSN: 21688370     Source Type: Journal    
DOI: 10.4161/21688370.2014.977176     Document Type: Review

References (116)

1. Anderson JM. Molecular structure of tight junctions and their role in epithelial transport. News Physiol Sci 2001; 16:126-30; PMID:11443232
2. Markov AG, Voronkova MA, Volgin GN, Yablonsky PK, Fromm M, Amasheh S. Tight junction proteins contribute to barrier properties in human pleura. Respir Physiol Neurobiol 2011; 175:331-5; PMID:21187167; http://dx.doi.org/10.1016/j. resp.2010.12.012
3. Amasheh S, Meiri N, Gitter AH, Schoneberg T, Mankertz J, Schulzke JD, Fromm M. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci 2002; 115:4969-76; PMID:12432083; http://dx.doi.org/10.1242/jcs.00165
4. Rosenthal R, Milatz S, Krug SM, Oelrich B, Schulzke JD, Amasheh S, Gunzel D, Fromm M. Claudin-2, a component of the tight junction, forms a paracellular water channel. J Cell Sci 2010; 123:1913-21; PMID:20460438; http://dx.doi.org/10.1242/jcs.060665
5. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998; 141:1539-50; PMID:9647647; http://dx.doi.org/10.1083/jcb.141.7.1539
6. Itoh M, Furuse M, Morita K, Kubota K, Saitou M, Tsukita S. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol 1999; 147:1351-63; PMID:10601346; http://dx.doi.org/10.1083/jcb.147.6.1351
7. Stiffler MA, Chen JR, Grantcharova VP, Lei Y, Fuchs D, Allen JE, Zaslavskaia LA, MacBeath G. PDZ domain binding selectivity is optimized across the mouse proteome. Science 2007; 317:364-9; PMID:17641200; http://dx.doi.org/10.1126/science.1144592
8. Furuse M, Sasaki H, Tsukita S. Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol 1999; 147:891-903; PMID:10562289; http://dx.doi.org/10.1083/jcb.147.4.891
9. Lim TS, Vedula SR, Hunziker W, Lim CT. Kinetics of adhesion mediated by extracellular loops of claudin-2 as revealed by single-molecule force spectroscopy. J Mol Biol 2008; 381:681-91; PMID:18635194; http://dx.doi.org/10.1016/j. jmb.2008.06.009
10. Van Itallie CM, Colegio OR, Anderson JM. The cytoplasmic tails of claudins can influence tight junction barrier properties through effects on protein stability. J Membr Biol 2004; 199:29-38; PMID:15366421; http://dx.doi.org/10.1007/s00232-004-0673-z
11. Angelow S, Yu AS. Cysteine mutagenesis to study the structure of claudin-2 paracellular pores. Ann N Y Acad Sci 2009; 1165:143-7; PMID:19538299; http://dx.doi.org/10.1111/j.1749-6632.2009.04038.x
12. Yu AS, Cheng MH, Angelow S, Gunzel D, Kanzawa SA, Schneeberger EE, Fromm M, Coalson RD. Molecular basis for cation selectivity in claudin-2-based paracellular pores: identification of an electrostatic interaction site. J Gen Physiol 2009; 133:111-27; PMID:19114638; http://dx.doi.org/10.1085/jgp.200810154
13. Angelow S, Ahlstrom R, Yu AS. Biology of claudins. Am J Physiol Renal Physiol 2008; 295:F867-76; PMID:18480174; http://dx.doi.org/10.1152/ajprenal.90264.2008
14. Li J, Angelow S, Linge A, Zhuo M, Yu AS. Claudin-2 pore function requires an intramolecular disulfide bond between two conserved extracellular cysteines. Am J Physiol Cell Physiol 2013; 305:C190-6; PMID:23677799; http://dx.doi.org/10.1152/ajpcell.00074.2013
15. Li J, Zhuo M, Pei L, Rajagopal M, Yu AS. Comprehensive cysteine-scanning mutagenesis reveals claudin-2 pore-lining residues with different intrapore locations. J Biol Chem 2014; 289:6475-84P; PMID:24436330
16. Li J, Zhuo M, Pei L, Yu AS. Conserved aromatic residue confers cation selectivity in claudin-2 and claudin-10b. J Biol Chem 2013; 288:22790-7; PMID:23760508; http://dx.doi.org/10.1074/jbc.M113.484238
17. Inai T, Sengoku A, Hirose E, Iida H, Shibata Y. Comparative characterization of mouse rectum CMT93-I and -II cells by expression of claudin isoforms and tight junction morphology and function. Histochem Cell Biol 2008; 129:223-32; PMID:18034259; http://dx.doi.org/10.1007/s00418-007-0360-0
18. Anderson JM, Van Itallie CM, Fanning AS. Setting up a selective barrier at the apical junction complex. Curr Opin Cell Biol 2004; 16:140-5; PMID:15196556; http://dx.doi.org/10.1016/j.ceb.2004.01.005
19. Furuse M, Furuse K, Sasaki H, Tsukita S. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 2001; 153:263-72; PMID:11309408; http://dx.doi.org/10.1083/jcb.153.2.263
20. Singh AB, Sugimoto K, Dhawan P, Harris RC. Juxtacrine activation of EGFR regulates claudin expression and increases transepithelial resistance. Am J Physiol Cell Physiol 2007; 293:C1660-8; PMID:17855771; http://dx.doi.org/10.1152/ajpcell.00274.2007
21. Enck AH, Berger UV, Yu AS. Claudin-2 is selectively expressed in proximal nephron in mouse kidney. Am J Physiol Renal Physiol 2001; 281:F966-74; PMID:11592954
22. Kiuchi-Saishin Y, Gotoh S, Furuse M, Takasuga A, Tano Y, Tsukita S. Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments. J Am Soc Nephrol 2002; 13:875-86; PMID:11912246
23. Lameris AL, Huybers S, Kaukinen K, Makela TH, Bindels RJ, Hoenderop JG, Nevalainen PI. Expression profiling of claudins in the human gastrointestinal tract in health and during inflammatory bowel disease. Scand J Gastroenterol 2013; 48:58-69; PMID:23205909; http://dx.doi.org/10.3109/00365521.2012.741616
24. Escaffit F, Boudreau F, Beaulieu JF. Differential expression of claudin-2 along the human intestine: implication of GATA-4 in the maintenance of claudin-2 in differentiating cells. J Cell Physiol 2005; 203:15-26; PMID:15389642; http://dx.doi.org/10.1002/jcp.20189
25. Tamura A, Hayashi H, Imasato M, Yamazaki Y, Hagiwara A, Wada M, Noda T, Watanabe M, Suzuki Y, Tsukita S. Loss of claudin-15, but not claudin-2, causes NaC deficiency and glucose malabsorption in mouse small intestine. Gastroenterology 2011; 140:913-23; PMID:20727355; http://dx.doi.org/10.1053/j.gastro.2010.08.006
26. Suzuki H, Nishizawa T, Tani K, Yamazaki Y, Tamura A, Ishitani R, Dohmae N, Tsukita S, Nureki O, Fujiyoshi Y. Crystal structure of a claudin provides insight into the architecture of tight junctions. Science 2014; 344:304-7; PMID:24744376; http://dx.doi.org/10.1126/science.1248571
27. Gunzel D, Fromm M. Claudins and other tight junction proteins. Compr Physiol 2012; 2:1819-52; PMID:23723025
28. Amasheh S, Dullat S, Fromm M, Schulzke JD, Buhr HJ, Kroesen AJ. Inflamed pouch mucosa possesses altered tight junctions indicating recurrence of inflammatory bowel disease. Int J Colorectal Dis 2009; 24:1149-56; PMID:19488769; http://dx.doi.org/10.1007/s00384-009-0737-8
29. Prasad S, Mingrino R, Kaukinen K, Hayes KL, Powell RM, MacDonald TT, Collins JE. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest 2005; 85:1139-62; PMID:16007110; http://dx.doi.org/10.1038/labinvest.3700316
30. Zeissig S, Burgel N, Gunzel D, Richter J, Mankertz J, Wahnschaffe U, Kroesen AJ, Zeitz M, Fromm M, Schulzke JD. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease. Gut 2007; 56:61-72; PMID:16822808; http://dx.doi.org/10.1136/gut.2006.094375
31. Heller F, Fromm A, Gitter AH, Mankertz J, Schulzke JD. Epithelial apoptosis is a prominent feature of the epithelial barrier disturbance in intestinal inflammation: effect of pro-inflammatory interleukin-13 on epithelial cell function. Mucosal Immunol 2008; 1 Suppl 1:S58-61; PMID:19079233; http://dx.doi.org/10.1038/mi.2008.46
32. Mankertz J, Amasheh M, Krug SM, Fromm A, Amasheh S, Hillenbrand B, Tavalali S, Fromm M, Schulzke JD. TNFalpha up-regulates claudin-2 expression in epithelial HT-29/B6 cells via phosphatidylinositol-3-kinase signaling. Cell Tissue Res 2009; 336:67-77; PMID:19214581; http://dx.doi.org/10.1007/s00441-009-0751-8
33. Suzuki T, Yoshinaga N, Tanabe S. Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium. J Biol Chem 2011; 286:31263-71; PMID:21771795; http://dx.doi.org/10.1074/jbc.M111.238147
34. Amasheh M, Fromm A, Krug SM, Amasheh S, Andres S, Zeitz M, Fromm M, Schulzke JD. TNFalpha-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFkappaB signaling. J Cell Sci 2010; 123:4145-55; PMID:21062898; http://dx.doi.org/10.1242/jcs.070896
35. Kinugasa T, Sakaguchi T, Gu X, Reinecker HC. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 2000; 118:1001-11; PMID:10833473; http://dx.doi.org/10.1016/S0016-5085(00)70351-9
36. Sakaguchi T, Gu X, Golden HM, Suh E, Rhoads DB, Reinecker HC. Cloning of the human claudin-2 5’-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1alpha. J Biol Chem 2002; 277:21361-70; PMID:11934881; http://dx.doi.org/10.1074/jbc.M110261200
37. Mankertz J, Hillenbrand B, Tavalali S, Huber O, Fromm M, Schulzke JD. Functional crosstalk between Wnt signaling and Cdx-related transcriptional activation in the regulation of the claudin-2 promoter activity. Biochem Biophys Res Commun 2004; 314:1001-7; PMID:14751232; http://dx.doi.org/10.1016/j.bbrc.2003.12.185
38. Boudreau F, Rings EH, van Wering HM, Kim RK, Swain GP, Krasinski SD, Moffett J, Grand RJ, Suh ER, Traber PG. Hepatocyte nuclear factor-1 alpha, GATA-4, and caudal related homeodomain protein Cdx2 interact functionally to modulate intestinal gene transcription. Implication for the developmental regulation of the sucrase-isomaltase gene. J Biol Chem 2002; 277:31909-17; PMID:12060663; http://dx.doi.org/10.1074/jbc.M204622200
39. Al-Sadi R, Ye D, Boivin M, Guo S, Hashimi M, Ereifej L, Ma TY. Interleukin-6 modulation of intestinal epithelial tight junction permeability is mediated by JNK pathway activation of claudin-2 gene. PLoS One 2014; 9:e85345; PMID:24662742; http://dx.doi.org/10.1371/journal.pone.0085345
40. Rosen MJ, Frey MR, Washington MK, Chaturvedi R, Kuhnhein LA, Matta P, Revetta FL, Wilson KT, Polk DB. STAT6 activation in ulcerative colitis: a new target for prevention of IL-13-induced colon epithelial cell dysfunction. Inflamm Bowel Dis 2011; 17:2224-34; PMID:21308881; http://dx.doi.org/10.1002/ibd.21628
41. Rosen MJ, Chaturvedi R, Washington MK, Kuhnhein LA, Moore PD, Coggeshall SS, McDonough EM, Weitkamp JH, Singh AB, Coburn LA, et al. STAT6 deficiency ameliorates severity of oxazolone colitis by decreasing expression of claudin-2 and Th2-inducing cytokines. J Immunol 2013; 190:1849-58; PMID:23303670; http://dx.doi.org/10.4049/jimmunol.1201373
42. Weber CR, Raleigh DR, Su L, Shen L, Sullivan EA, Wang Y, Turner JR. Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity. J Biol Chem 2010; 285:12037-46; PMID:20177070; http://dx.doi.org/10.1074/jbc.M109.064808
43. Mazzon E, Cuzzocrea S. Absence of functional peroxisome proliferator-activated receptor-alpha enhanced ileum permeability during experimental colitis. Shock 2007; 28:192-201; PMID:17515853; http://dx.doi.org/10.1097/SHK.0b013e318033eb29
44. Gonzalez-Mariscal L, Garay E, Quiros M. Regulation of claudins by posttranslational modifications and cell-signaling cascades. Curr Top Membr 65: 113-150, 2010.
45. Van Itallie CM, Tietgens AJ, LoGrande K, Aponte A, Gucek M, Anderson JM. Phosphorylation of claudin-2 on serine 208 promotes membrane retention and reduces trafficking to lysosomes. J Cell Sci 2012; 125:4902-12; PMID:22825868; http://dx.doi.org/10.1242/jcs.111237
46. Van Itallie CM, Mitic LL, Anderson JM. SUMOylation of claudin-2. Ann N Y Acad Sci 2012; 1258:60-4; PMID:22731716; http://dx.doi.org/10.1111/j.1749-6632.2012.06541.x
47. Angelow S, Schneeberger EE, Yu AS. Claudin-8 expression in renal epithelial cells augments the paracellular barrier by replacing endogenous claudin-2. J Membr Biol 2007; 215:147-59; PMID:17516019; http://dx.doi.org/10.1007/s00232-007-9014-3
48. Yu AS, Enck AH, Lencer WI, Schneeberger EE. Claudin-8 expression in Madin-Darby canine kidney cells augments the paracellular barrier to cation permeation. J Biol Chem 2003; 278:17350-9; PMID:12615928; http://dx.doi.org/10.1074/jbc.M213286200
49. Epple HJ, Zeitz M. Intestinal mucosal barrier function in HIV infection. Ann. N.Y. Acad. Sci. 2012; 1258:19-24.
50. Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, Mankertz J, Gitter AH, Burgel N, Fromm M, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 2005; 129:550-64; PMID:16083712; http://dx.doi.org/10.1016/j.gastro.2005.05.002
51. Oshima T, Miwa H, Joh T. Changes in the expression of claudins in active ulcerative colitis. J Gastroenterol Hepatol 2008; 23 Suppl 2:S146-50; PMID:19120888; http://dx.doi.org/10.1111/j.1440-1746.2008.05405.x
52. Schumann M, Gunzel D, Buergel N, Richter JF, Troeger H, May C, Fromm A, Sorgenfrei D, Daum S, Bojarski C, et al. Cell polarity-determining proteins Par-3 and PP-1 are involved in epithelial tight junction defects in coeliac disease. Gut 2011; 61:220-8; PMID:21865402; http://dx.doi.org/10.1136/gutjnl-2011-300123
53. Das P, Goswami P, Das TK, Nag T, Sreenivas V, Ahuja V, Panda SK, Gupta SD, Makharia GK. Comparative tight junction protein expressions in colonic Crohn’s disease, ulcerative colitis, and tuberculosis: a new perspective. Virchows Arch 2012; 460:261-70; PMID:22297703; http://dx.doi.org/10.1007/s00428-012-1195-1
54. Marchiando AM, Shen L, Graham WV, Weber CR, Schwarz BT, Austin JR 2nd, Raleigh DR, Guan Y, Watson AJ, Montrose MH, et al. Caveolin-1-dependent occludin endocytosis is required for TNFinduced tight junction regulation in vivo. J Cell Biol 2010; 189:111-26; PMID:20351069; http://dx.doi.org/10.1083/jcb.200902153
55. Desreumaux P, Brandt E, Gambiez L, Emilie D, Geboes K, Klein O, Ectors N, Cortot A, Capron M, Colombel JF. Distinct cytokine patterns in early and chronic ileal lesions of Crohn’s disease. Gastroenterology 1997; 113:118-26; PMID:9207269; http://dx.doi.org/10.1016/S0016-5085(97)70116-1
56. Knutson L, Ahrenstedt O, Odlind B, Hallgren R. The jejunal secretion of histamine is increased in active Crohn’s disease. Gastroenterology 1990; 98:849-54; PMID:1690156; http://dx.doi.org/10.1016/0016-5085(90)90006-M
57. Zorzi F, Monteleone I, Sarra M, Calabrese E, Marafini I, Cretella M, Sedda S, Biancone L, Pallone F, Monteleone G. Distinct profiles of effector cytokines mark the different phases of Crohn’s disease. PLoS One 2013; 8:e54562; PMID:23349929; http://dx.doi.org/10.1371/journal.pone.0054562
58. Andoh A, Zhang Z, Inatomi O, Fujino S, Deguchi Y, Araki Y, Tsujikawa T, Kitoh K, Kim-Mitsuyama S, Takayanagi A, et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 2005; 129:969-84; PMID:16143135; http://dx.doi.org/10.1053/j.gastro.2005.06.071
59. Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte JM, Diepolder H, Marquardt A, Jagla W, Popp A, et al. IL-22 is increased in active Crohn’s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 2006; 290:G827-38; PMID:16537974; http://dx.doi.org/10.1152/ajpgi.00513.2005
60. John LJ, Fromm M, Schulzke JD. Epithelial barriers in intestinal inflammation. Antioxid Redox Signal 2011; 15:1255-70; PMID:21294654; http://dx.doi.org/10.1089/ars.2011.3892
61. Amasheh M, Grotjohann I, Amasheh S, Fromm A, Soderholm JD, Zeitz M, Fromm M, Schulzke JD. Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines. Scand J Gastroenterol 2009; 44:1226-35; PMID:19658020; http://dx.doi.org/10.1080/00365520903131973
62. Blair SA, Kane SV, Clayburgh DR, Turner JR. Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease. Lab Invest 2006; 86:191-201; PMID:16402035; http://dx.doi.org/10.1038/labinvest.3700373
63. Al-Sadi R, Ye D, Said HM, Ma TY. Cellular and molecular mechanism of interleukin-1beta modulation of Caco-2 intestinal epithelial tight junction barrier. J Cell Mol Med 2011; 15:970-82; PMID:20406328; http://dx.doi.org/10.1111/j.1582-4934.2010.01065.x
64. Ye D, Ma TY. Cellular and molecular mechanisms that mediate basal and tumour necrosis factor-alphainduced regulation of myosin light chain kinase gene activity. J Cell Mol Med 2008; 12:1331-46; PMID:18363837; http://dx.doi.org/10.1111/j.1582-4934.2008.00302.x
65. Shen L, Black ED, Witkowski ED, Lencer WI, Guerriero V, Schneeberger EE, Turner JR. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci 2006; 119:2095-106; PMID:16638813; http://dx.doi.org/10.1242/jcs.02915
66. Bruewer M, Utech M, Ivanov AI, Hopkins AM, Parkos CA, Nusrat A. Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. Faseb J 2005; 19:923-33; PMID:15923402; http://dx.doi.org/10.1096/fj.04-3260com
67. Irvine EJ, Marshall JK. Increased intestinal permeability precedes the onset of Crohn’s disease in a subject with familial risk. Gastroenterology 2000; 119:1740-4; PMID:11113095; http://dx.doi.org/10.1053/gast.2000.20231
68. Wyatt J, Vogelsang H, Hubl W, Waldhoer T, Lochs H. Intestinal permeability and the prediction of relapse in Crohn’s disease. Lancet 1993; 341:1437-9; PMID:8099141; http://dx.doi.org/10.1016/0140-6736(93)90882-H
69. Lala S, Ogura Y, Osborne C, Hor SY, Bromfield A, Davies S, Ogunbiyi O, Nunez G, Keshav S. Crohn’s disease and the NOD2 gene: a role for paneth cells. Gastroenterology 2003; 125:47-57; PMID:12851870; http://dx.doi.org/10.1016/S0016-5085(03)00661-9
70. Buhner S, Buning C, Genschel J, Kling K, Herrmann D, Dignass A, Kuechler I, Krueger S, Schmidt HH, Lochs H. Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation? Gut 2006; 55:342-7; PMID:16000642; http://dx.doi.org/10.1136/gut.2005.065557
71. D’Inca R, Annese V, di Leo V, Latiano A, Quaino V, Abazia C, Vettorato MG, Sturniolo GC. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn’s disease. Aliment Pharmacol Ther 2006; 23:1455-61; PMID:16669960; http://dx.doi.org/10.1111/j.1365-2036.2006.02916.x
72. Voss E, Wehkamp J, Wehkamp K, Stange EF, Schroder JM, Harder J. NOD2/CARD15 mediates induction of the antimicrobial peptide human betadefensin-2. J Biol Chem 2006; 281:2005-11; PMID:16319062; http://dx.doi.org/10.1074/jbc.M511044200
73. Wehkamp J, Harder J, Weichenthal M, Schwab M, Schaffeler E, Schlee M, Herrlinger KR, Stallmach A, Noack F, Fritz P, et al. NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal alpha-defensin expression. Gut 2004; 53:1658-64; PMID:15479689; http://dx.doi.org/10.1136/gut.2003.032805
74. Rosenstiel P, Fantini M, Brautigam K, Kuhbacher T, Waetzig GH, Seegert D, Schreiber S. TNFalpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 2003; 124:1001-9; PMID:12671897; http://dx.doi.org/10.1053/gast.2003.50157
75. Bucker R, Troeger H, Kleer J, Fromm M, Schulzke JD. Arcobacter butzleri induces barrier dysfunction in intestinal HT-29/B6 cells. J Infect Dis 2009; 200:756-64; PMID:19604116; http://dx.doi.org/10.1086/600868
76. Hering NA, Richter JF, Krug SM, Gunzel D, Fromm A, Bohn E, Rosenthal R, Bucker R, Fromm M, Troeger H, et al. Yersinia enterocolitica induces epithelial barrier dysfunction through regional tight junction changes in colonic HT-29/B6 cell monolayers. Lab Invest 2011; 91:310-24; PMID:20956974; http://dx.doi.org/10.1038/labinvest.2010.180
77. Barreau F, Meinzer U, Chareyre F, Berrebi D, Niwa-Kawakita M, Dussaillant M, Foligne B, Ollendorff V, Heyman M, Bonacorsi S, et al. CARD15/NOD2 is required for Peyer’s patches homeostasis in mice. PLoS One 2007; 2:e523; PMID:17565376; http://dx.doi.org/10.1371/journal.pone.0000523
78. Wisner DM, Harris LR 3rd, Green CL, Poritz LS. Opposing regulation of the tight junction protein claudin-2 by interferon-gamma and interleukin-4. J Surg Res 2008; 144:1-7; PMID:17640674; http://dx.doi.org/10.1016/j.jss.2007.03.059
79. Olson TS, Reuter BK, Scott KG, Morris MA, Wang XM, Hancock LN, Burcin TL, Cohn SM, Ernst PB, Cominelli F, et al. The primary defect in experimental ileitis originates from a nonhematopoietic source. J Exp Med 2006; 203:541-52; PMID:16505137; http://dx.doi.org/10.1084/jem.20050407
80. Gitter AH, Wullstein F, Fromm M, Schulzke JD. Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology 2001; 121:1320-8; PMID:11729111; http://dx.doi.org/10.1053/gast.2001.29694
81. Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ, Riecken EO, Schulzke JD. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 1999; 116:301-9; PMID:9922310; http://dx.doi.org/10.1016/S0016-5085(99)70126-5
82. Bojarski C, Gitter AH, Bendfeldt K, Mankertz J, Schmitz H, Wagner S, Fromm M, Schulzke JD. Permeability of human HT-29/B6 colonic epithelium as a function of apoptosis. J Physiol 2001; 535:541-52; PMID:11533143; http://dx.doi.org/10.1111/j.1469-7793.2001.00541.x
83. Gitter AH, Bendfeldt K, Schulzke JD, Fromm M. Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis. Faseb J 2000; 14:1749-53; PMID:10973924; http://dx.doi.org/10.1096/fj.99-0898com
84. Ahn SH, Shah YM, Inoue J, Morimura K, Kim I, Yim S, Lambert G, Kurotani R, Nagashima K, Gonzalez FJ, et al. Hepatocyte nuclear factor 4alpha in the intestinal epithelial cells protects against inflammatory bowel disease. Inflamm Bowel Dis 2008; 14:908-20; PMID:18338782; http://dx.doi.org/10.1002/ibd.20413
85. Cattin AL, Le Beyec J, Barreau F, Saint-Just S, Houllier A, Gonzalez FJ, Robine S, Pincon-Raymond M, Cardot P, Lacasa M, et al. Hepatocyte nuclear factor 4alpha, a key factor for homeostasis, cell architecture, and barrier function of the adult intestinal epithelium. Mol Cell Biol 2009; 29:6294-308; PMID:19805521; http://dx.doi.org/10.1128/MCB.00939-09
86. Visser J, Rozing J, Sapone A, Lammers K, Fasano A. Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci 2009; 1165:195-205; PMID:19538307; http://dx.doi.org/10.1111/j.1749-6632.2009.04037.x
87. Matysiak-Budnik T, Candalh C, Dugave C, Namane A, Cellier C, Cerf-Bensussan N, Heyman M. Alterations of the intestinal transport and processing of gliadin peptides in celiac disease. Gastroenterology 2003; 125:696-707; PMID:12949716; http://dx.doi.org/10.1016/S0016-5085(03)01049-7
88. Schumann M, Richter JF, Wedell I, Moos V, Zimmermann-Kordmann M, Schneider T, Daum S, Zeitz M, Fromm M, Schulzke JD. Mechanisms of epithelial translocation of the alpha(2)-gliadin-33mer in coeliac sprue. Gut 2008; 57:747-54; PMID:18305066
89. Ciccocioppo R, Finamore A, Ara C, Di Sabatino A, Mengheri E, Corazza GR. Altered expression, localization, and phosphorylation of epithelial junctional proteins in celiac disease. Am J Clin Pathol 2006; 125:502-11; PMID:16627260; http://dx.doi.org/10.1309/DTYRA91G8R0KTM8M
90. Schumann M, Kamel S, Pahlitzsch ML, Lebenheim L, May C, Krauss M, Hummel M, Daum S, Fromm M, Schulzke JD. Defective tight junctions in refractory celiac disease. Ann N Y Acad Sci 2012; 1258:43-51; PMID:22731714; http://dx.doi.org/10.1111/j.1749-6632.2012.06565.x
91. Szakal DN, Gyorffy H, Arato A, Cseh A, Molnar K, Papp M, Dezsofi A, Veres G. Mucosal expression of claudins 2, 3 and 4 in proximal and distal part of duodenum in children with coeliac disease. Virchows Arch 2010; 456:245-50; PMID:20143085; http://dx.doi.org/10.1007/s00428-009-0879-7
92. van Elburg RM, Uil JJ, Mulder CJ, Heymans HS. Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease. Gut 1993; 34:354-7; PMID:8472983; http://dx.doi.org/10.1136/gut.34.3.354
93. Menard S, Lebreton C, Schumann M, Matysiak-Budnik T, Dugave C, Bouhnik Y, Malamut G, Cellier C, Allez M, Crenn P, et al. Paracellular versus transcellular intestinal permeability to gliadin peptides in active celiac disease. Am J Pathol 2012; 180:608-15; PMID:22119716; http://dx.doi.org/10.1016/j.ajpath.2011.10.019
94. Kohl D, Ashkenazi A, Ben-Shaul Y, Bacher A. Tight junctions of jejunal surface and crypt cells in celiac disease: a freeze-fracture study. J Pediatr Gastroenterol Nutr 1987; 6:57-65; PMID:3794934
95. Schulzke JD, Bentzel CJ, Schulzke I, Riecken EO, Fromm M. Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue. Pediatr Res 1998; 43:435-41; PMID:9544995; http://dx.doi.org/10.1203/00006450-199804000-00001
96. Utech M, Ivanov AI, Samarin SN, Bruewer M, Turner JR, Mrsny RJ, Parkos CA, Nusrat A. Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell 2005; 16:5040-52; PMID:16055505; http://dx.doi.org/10.1091/mbc.E05-03-0193
97. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-71; PMID:17115046; http://dx.doi.org/10.1038/nm1511
98. Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, Nguyen PL, Khoruts A, Larson M, Haase AT, et al. CD4C T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749-59; PMID:15365096; http://dx.doi.org/10.1084/jem.20040874
99. Epple HJ, Allers K, Troger H, Kuhl A, Erben U, Fromm M, Zeitz M, Loddenkemper C, Schulzke JD, Schneider T. Acute HIV infection induces mucosal infiltration with CD4C and CD8C T cells, epithelial apoptosis, and a mucosal barrier defect. Gastroenterology 2010; 139:1289-300; PMID:20600014; http://dx.doi.org/10.1053/j.gastro.2010.06.065
100. Epple HJ, Schneider T, Troeger H, Kunkel D, Allers K, Moos V, Amasheh M, Loddenkemper C, Fromm M, Zeitz M, et al. Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients. Gut 2009; 58:220-7; PMID:18936106; http://dx.doi.org/10.1136/gut.2008.150425
101. Nazli A, Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, Gray-Owen SD, Arsenault AL, Kaushic C. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog 2010; 6:e1000852; PMID:20386714; http://dx.doi.org/10.1371/journal. ppat.1000852
102. Sankaran S, George MD, Reay E, Guadalupe M, Flamm J, Prindiville T, Dandekar S. Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J Virol 2008; 82:538-45; PMID:17959677; http://dx.doi.org/10.1128/JVI.01449-07
103. Fackler OT, Schafer M, Schmidt W, Zippel T, Heise W, Schneider T, Zeitz M, Riecken EO, Mueller-Lantzsch N, Ullrich R. HIV-1 p24 but not proviral load is increased in the intestinal mucosa compared with the peripheral blood in HIV-infected patients. Aids 1998; 12:139-46; PMID:9468362; http://dx.doi.org/10.1097/00002030-199802000-00003
104. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M. Massive infection and loss of memory CD4C T cells in multiple tissues during acute SIV infection. Nature 2005; 434:1093-7; PMID:15793563; http://dx.doi.org/10.1038/nature03501
105. Buccigrossi V, Laudiero G, Nicastro E, Miele E, Esposito F, Guarino A. The HIV-1 transactivator factor (Tat) induces enterocyte apoptosis through a redoxmediated mechanism. PLoS One 2011; 6:e29436; PMID:22216281; http://dx.doi.org/10.1371/journal. pone.0029436
106. Clayton F, Kotler DP, Kuwada SK, Morgan T, Stepan C, Kuang J, Le J, Fantini J. Gp120-induced Bob/GPR15 activation: a possible cause of human immunodeficiency virus enteropathy. Am J Pathol 2001; 159:1933-9; PMID:11696454; http://dx.doi.org/10.1016/S0002-9440(10)63040-4
107. Quigley MA, Kamali A, Kinsman J, Kamulegeya I, Nakiyingi-Miiro J, Kiwuwa S, Kengeya-Kayondo JF, Carpenter LM, Whitworth JA. The impact of attending a behavioural intervention on HIV incidence in Masaka, Uganda. Aids 2004; 18:2055-63; PMID:15577627; http://dx.doi.org/10.1097/00002030-200410210-00010
108. Shacklett BL, Cox CA, Quigley MF, Kreis C, Stollman NH, Jacobson MA, Andersson J, Sandberg JK, Nixon DF. Abundant expression of granzyme A, but not perforin, in granules of CD8C T cells in GALT: implications for immune control of HIV-1 infection. J Immunol 2004; 173:641-8; PMID:15210827; http://dx.doi.org/10.4049/jimmunol.173.1.641
109. Kim CJ, Nazli A, Rojas OL, Chege D, Alidina Z, Huibner S, Mujib S, Benko E, Kovacs C, Shin LY, et al. A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis. Mucosal Immunol 2012; 5:670-80; PMID:22854709; http://dx.doi.org/10.1038/mi.2012.72
110. Fischer A, Gluth M, Pape UF, Wiedenmann B, Theuring F, Baumgart DC. Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNFalpha on tight junction proteins and signaling pathways in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2013; 304:G970-9; PMID:23538493; http://dx.doi.org/10.1152/ajpgi.00183.2012
111. Vieira EL, Leonel AJ, Sad AP, Beltrao NR, Costa TF, Ferreira TM, Gomes-Santos AC, Faria AM, Peluzio MC, Cara DC, et al. Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. J Nutr Biochem 2012; 23:430-6; PMID:21658926; http://dx.doi.org/10.1016/j.jnutbio.2011.01.007
112. Daly K, Shirazi-Beechey SP. Microarray analysis of butyrate regulated genes in colonic epithelial cells. DNA Cell Biol 2006; 25:49-62; PMID:16405400; http://dx.doi.org/10.1089/dna.2006.25.49
113. Ploger S, Stumpff F, Penner GB, Schulzke JD, Gabel G, Martens H, Shen Z, Gunzel D, Aschenbach JR. Microbial butyrate and its role for barrier function in the gastrointestinal tract. Ann N Y Acad Sci 2012; 1258:52-9; PMID:22731715; http://dx.doi.org/10.1111/j.1749-6632.2012.06553.x
114. Zhang Q, Piao XL, Piao XS, Lu T, Wang D, Kim SW. Preventive effect of Coptis chinensis and berberine on intestinal injury in rats challenged with lipopolysaccharides. Food Chem Toxicol 2011; 49:61-9; PMID:20932871; http://dx.doi.org/10.1016/j.fct.2010.09.032
115. Wang N, Yu H, Ma J, Wu W, Zhao D, Shi X, Tian H, Jiang H. Evidence for tight junction protein disruption in intestinal mucosa of malignant obstructive jaundice patients. Scand J Gastroenterol 2010; 45:191-9; PMID:20095884; http://dx.doi.org/10.3109/00365520903406701
116. Burgel N, Bojarski C, Mankertz J, Zeitz M, Fromm M, Schulzke JD. Mechanisms of diarrhea in collagenous colitis. Gastroenterology 2002; 123:433-43; PMID:12145796; http://dx.doi.org/10.1053/gast.2002.34784